Cargando…

Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry

BACKGROUND: Despite strong recommendations for coronavirus disease 2019 (Covid-19) vaccination by multiple sclerosis (MS) organizations, some persons with MS (pwMS) remain vaccine hesitant. The Swiss MS Registry conducted a survey to explore Covid-19 vaccine hesitancy, self-reported side effects and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stanikić, Mina, Twomey, Eric, Puhan, Milo A., Kamm, Christian P., Salmen, Anke, Ajdacic-Gross, Vladeta, Zecca, Chiara, Gobbi, Claudio, von Wyl, Viktor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier B.V. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080862/ https://www.ncbi.nlm.nih.gov/pubmed/37068368 http://dx.doi.org/10.1016/j.msard.2023.104707

Ejemplares similares

The Swiss Multiple Sclerosis Registry (SMSR): study protocol of a participatory, nationwide registry to promote epidemiological and patient-centered MS research
por: Steinemann, Nina, et al.
Publicado: (2018)

The Effect of Depression on Health-Related Quality of Life Is Mediated by Fatigue in Persons with Multiple Sclerosis
por: Rodgers, Stephanie, et al.
Publicado: (2021)

Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors
por: Ajdacic-Gross, Vladeta, et al.
Publicado: (2021)

Factors associated with employment and expected work retention among persons with multiple sclerosis: findings of a cross-sectional citizen science study
por: Lehmann, Anja I., et al.
Publicado: (2020)

How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis
por: Barin, Laura, et al.
Publicado: (2019)

Blending citizen science with natural language processing and machine learning: Understanding the experience of living with multiple sclerosis
por: Haag, Christina, et al.
Publicado: (2023)

The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing
por: Chiavi, Deborah, et al.
Publicado: (2022)

Feelings of loneliness, COVID-19-specific-health anxiety and depressive symptoms during the first COVID-19 wave in Swiss persons with multiple sclerosis
por: Hoepner, Robert, et al.
Publicado: (2022)

Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland
por: Kaufmann, Marco, et al.
Publicado: (2018)

60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments
por: Kaufmann, Marco, et al.
Publicado: (2020)

A Framework for Estimating the Burden of Chronic Diseases: Design and Application in the Context of Multiple Sclerosis
por: Kaufmann, Marco, et al.
Publicado: (2019)

Electronic Health Diary Campaigns to Complement Longitudinal Assessments in Persons With Multiple Sclerosis: Nested Observational Study
por: Sieber, Chloé, et al.
Publicado: (2022)

Real‐life long‐term effectiveness of fingolimod in Swiss patients with relapsing‐remitting multiple sclerosis
por: Zecca, C., et al.
Publicado: (2018)

Use of glatiramer acetate between 2010–2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients
por: Zecca, Chiara, et al.
Publicado: (2019)

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
por: Disanto, Giulio, et al.
Publicado: (2017)

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options
por: Disanto, Giulio, et al.
Publicado: (2016)

Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland
por: Scotti, Barbara, et al.
Publicado: (2018)

SWiss Atorvastatin and Interferon Beta-1b Trial In Multiple Sclerosis (SWABIMS) - rationale, design and methodology
por: Kamm, Christian P, et al.
Publicado: (2009)

Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?
por: Hoepner, Robert, et al.
Publicado: (2022)

The Swiss chiropractic practice-based research network: a population-based cross-sectional study to inform future musculoskeletal research
por: Lalji, Rahim, et al.
Publicado: (2023)

Long-term worsening of different body functions in persons with progressive multiple sclerosis
por: Kaufmann, Marco, et al.
Publicado: (2020)

Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis—A Cohort Study
por: Findling, Oliver, et al.
Publicado: (2015)

The Danish Multiple Sclerosis Registry
por: Magyari, Melinda, et al.
Publicado: (2020)

Fatigue, sleepiness and depression in multiple sclerosis: defining the overlaps for a better phenotyping
por: Sparasci, Davide, et al.
Publicado: (2022)

Swiss chiropractic practice-based research network and musculoskeletal pain cohort pilot study: protocol of a nationwide resource to advance musculoskeletal health services research
por: Lalji, Rahim, et al.
Publicado: (2022)

The Prevention of Mental Disorders has a Bright Future
por: Ajdacic-Gross, Vladeta
Publicado: (2014)

Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis
por: Hoepner, Robert, et al.
Publicado: (2014)

Recurrence and Prognostic Value of Asymptomatic Spinal Cord Lesions in Multiple Sclerosis
por: Ostini, Camilla, et al.
Publicado: (2021)

Individual-Level Evaluation of the Exposure Notification Cascade in the SwissCovid Digital Proximity Tracing App: Observational Study
por: Ballouz, Tala, et al.
Publicado: (2022)

Migraine in Multiple Sclerosis Patients Affects Functional Connectivity of the Brain Circuitry Involved in Pain Processing
por: Pravatà, Emanuele, et al.
Publicado: (2021)

Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study
por: Zecca, Chiara, et al.
Publicado: (2017)

Incidence of malignancy in multiple sclerosis: A cohort study in the Danish Multiple Sclerosis Registry
por: Nørgaard, Mette, et al.
Publicado: (2021)

Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS)
por: Achtnichts, Lutz, et al.
Publicado: (2023)

Toward a Working Definition of eCohort Studies in Health Research: Narrative Literature Review
por: Nittas, Vasileios, et al.
Publicado: (2021)

Increasing cancer risk over calendar year in people with multiple sclerosis: a case–control study
por: Zecca, Chiara, et al.
Publicado: (2020)

Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis
por: Marti, Stefanie, et al.
Publicado: (2023)

Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing–remitting multiple sclerosis treatment
por: Caporro, Matteo, et al.
Publicado: (2014)

Therapies for multiple sclerosis targeting B cells
por: Milo, Ron
Publicado: (2019)

Role of Family Planning in Women With Multiple Sclerosis in Switzerland: Results of the Women With Multiple Sclerosis Patient Survey
por: Kamm, Christian P., et al.
Publicado: (2018)

Non-equivalent, but still valid: Establishing the construct validity of a consumer fitness tracker in persons with multiple sclerosis
por: Polhemus, Ashley, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ljgoaisvopva3q51tg12qar0el